We previously reported that ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism; in that study, we demonstrated that pathologic stimuli, such as hypertension, increase cardiomyocyte ANGPTL2 expression, leading to a predisposition to heart failure45. This evidence concerns the gene ANGPTL2 and heart failure.